Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis-Reference-Cited by-同舟云学术

Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis

Published:2015-03 Issue:3 Volume:15 Page:293-300
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Izurieta Hector S,Thadani Nicole,Shay David K,Lu Yun,Maurer Aaron,Foppa Ivo M,Franks Riley,Pratt Douglas,Forshee Richard A,MaCurdy Thomas,Worrall Chris,Howery Andrew E,Kelman Jeffrey

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference31 articles.

1. Influenza-associated hospitalizations in the United States;Thompson;JAMA,2004

2. Mortality associated with influenza and respiratory syncytial virus in the United States;Thompson;JAMA,2003

3. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008;Zhou;Clin Infect Dis,2012

4. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial;Govaert;BMJ,1993

5. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial;Govaert;JAMA,1994

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing higher-dose and single standard-dose influenza vaccines in preventing cardiovascular events: a meta-analysis with 68,713 patients;Public Health;2024-10

2. Infectious Disease Updates for Primary Care;Medical Clinics of North America;2024-09

3. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–25 Influenza Season;MMWR. Recommendations and Reports;2024-08-29

4. Comparative Effectiveness of Licensed Influenza Vaccines in Preventing Influenza-related Medical Encounters and Hospitalizations in the 2022–2023 Influenza Season Among Adults ≥65 Years of Age;Clinical Infectious Diseases;2024-08-21

5. Feasibility and Findings of Including Self-Identified Adult Congenital Heart Disease Patients in the INVESTED Trial;JACC: Advances;2024-04